APA

Culbert A. A., Brown M. J., Frame S., Hagen T., Cross D. A., Bax B. & Reith A. D. (20011231). GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity. : FEBS letters.

Chicago

Culbert A A, Brown M J, Frame S, Hagen T, Cross D A, Bax B and Reith A D. 20011231. GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity. : FEBS letters.

Harvard

Culbert A. A., Brown M. J., Frame S., Hagen T., Cross D. A., Bax B. and Reith A. D. (20011231). GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity. : FEBS letters.

MLA

Culbert A A, Brown M J, Frame S, Hagen T, Cross D A, Bax B and Reith A D. GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity. : FEBS letters. 20011231.